Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.58 |
| ▸ | POLB | P06746 | 4/20 | 0.58 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.56 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.52 |
| ▸ | HTT | P42858 | 1/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 2/20 | 0.48 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | ACLY | P53396 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11634297 | 0.89 | GSTO1 (0.46) | KMT2ASMN1; SMN2POLBHSD17B10KDM4E | |
| SCHEMBL11634252 | 0.85 | SMN1; SMN2 (0.42) | KMT2ASMN1; SMN2POLBHSD17B10KDM4E | |
| SCHEMBL11930743 | 0.84 | POLB (0.62) | KMT2ASMN1; SMN2POLBHSD17B10KDM4E | |
| SCHEMBL11026357 | 0.80 | POLB (0.65) | KMT2ASMN1; SMN2POLBHSD17B10KDM4E | |
| SCHEMBL9436722 | 0.80 | POLB (0.58) | KMT2ASMN1; SMN2POLBHSD17B10KDM4E | |
| SCHEMBL9885777 | 0.80 | KDM4E (0.60) | KMT2ASMN1; SMN2POLBHSD17B10KDM4E | |
| SCHEMBL8067660 | 0.79 | POLB (0.62) | KMT2ASMN1; SMN2POLBHSD17B10KDM4E | |
| SCHEMBL14177874 | 0.78 | KDM4E (0.49) | KMT2ASMN1; SMN2POLBHSD17B10KDM4E | |
| SCHEMBL11595503 | 0.78 | POLB (0.56) | KMT2ASMN1; SMN2POLBHSD17B10KDM4E | |
| SCHEMBL11595561 | 0.78 | POLB (0.62) | KMT2ASMN1; SMN2POLBHSD17B10KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2007130890-A2 | CYCLOPENTANE-DERIVATIVES AND THEIR USE AS OCULAR HYPOTENSIVE AGENTS | ALLERGAN, INC. (US) | 2007-11-15 | — | — | WO | disclosed |